In the combined CF and BBP treatment group, the protein expression of EDN1 and GRB2 was significantly downregulated as opposed to that in the model group, and the regression trend was more significant than that observed with CF or BBP administration alone (Fig. 4g, h). Here, EDN1 is linked to cystic fibrosis.